HCA Latest Quarter's Earnings
| Announce Date | 01/24/2025 |
| EPS Normalized Actual | $6.22 (Beat by $0.09) |
| EPS GAAP Actual | $6.22 (Beat by $0.09) |
| Revenue Actual | $18.285B |
| Revenue Surprise | Beat by $18285M |
Upcoming Quarter's Earnings
| Announce Date | 03/31/2025 (Pre-Market) |
| EPS Normalized Estimate | $5.76167 |
| EPS GAAP Estimate | $5.76167 |
| Revenue Estimate | $17.870295563B |
Annual EPS Estimate
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0 | INF | 0 | 0 | 5 |
| Dec 2028 | 0 | INF | 0 | 0 | 6 |
Quarterly EPS History
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2024 (Dec 2024) | 5.63 | 5.63 | 18.285B | 5.37% | 18285M |
| FQ3 2024 (Sep 2024) | -11.5 | -11.5 | 17.487B | 7.29% | 17487M |
| FQ2 2024 (Jun 2024) | 0 | 0 | 17.492B | 9.32% | 17492M |
| FQ1 2024 (Mar 2024) | 5.93 | 5.93 | 17.339B | 10.08% | 17339M |
| FQ4 2023 (Dec 2023) | 6.05 | 6.05 | 17.303B | 10.44% | 17303M |
| FQ3 2023 (Sep 2023) | 3.97 | 3.97 | 16.213B | 7.66% | 16213M |
| FQ2 2023 (Jun 2023) | 4.34 | 4.34 | 15.861B | 6.56% | 15861M |
| FQ1 2023 (Mar 2023) | 4.92 | 4.92 | 15.591B | 100% | 15591M |
Quarterly Estimates Summary
FQ4 Announce Date
03/31/2025 (Pre-Market)
Consensus EPS Estimates
5.76167
Consensus Revenue Estimates
17.870295563B
Consensus EPS Estimates
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 8.77 | -- | 8.61917 | 8.90532 | 8 |
| FQ3 2027 (Sep 2027) | 7 | -- | 6.87961 | 7.10801 | 8 |
| FQ2 2027 (Jun 2027) | 7.42 | -- | 7.29238 | 7.53449 | 8 |
| FQ1 2027 (Mar 2027) | 7.26 | -- | 7.13514 | 7.37202 | 8 |
| FQ4 2026 (Oct 2026) | 5.91422 | -- | 5.82282 | 6.04434 | 3 |
| FQ3 2026 (Jul 2026) | 6.01838 | -- | 5.92537 | 6.15079 | 5 |
| FQ2 2026 (Jun 2026) | 6.12172 | -- | 5.98359 | 6.26303 | 9 |
| FQ1 2026 (Mar 2026) | 5.8933 | -- | 5.76032 | 6.02933 | 9 |
| FQ4 2025 (Oct 2025) | 5.25776 | -7.08 | 5.1765 | 5.37344 | 4 |
| FQ3 2025 (Jul 2025) | 5.57114 | 306.42 | 5.48504 | 5.69371 | 6 |
| FQ2 2025 (Jun 2025) | 5.58992 | -- | 5.46379 | 5.71895 | 6 |
| FQ1 2025 (Mar 2025) | 5.76167 | -2.92 | 5.67262 | 5.88843 | 4 |
Consensus Revenue Estimates
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 21.35B | -- | 21.07B | 21.6B | 9 |
| FQ3 2027 (Sep 2027) | 20.67B | -- | 20.39B | 20.91B | 9 |
| FQ2 2027 (Jun 2027) | 20.52B | -- | 20.25B | 20.76B | 9 |
| FQ1 2027 (Mar 2027) | 20.31B | -- | 20.04B | 20.55B | 9 |
| FQ4 2026 (Oct 2026) | 19.2B | -- | 18.97B | 19.52B | 4 |
| FQ3 2026 (Jul 2026) | 19.14B | -- | 18.92B | 19.47B | 6 |
| FQ2 2026 (Jun 2026) | 19.01B | -- | 18.68B | 19.35B | 6 |
| FQ1 2026 (Mar 2026) | 18.54B | -- | 18.22B | 18.87B | 12 |
| FQ4 2025 (Oct 2025) | 18.11B | -0.97 | 17.89B | 18.42B | 3 |
| FQ3 2025 (Jul 2025) | 17.95B | 2.6 | 17.74B | 18.26B | 5 |
| FQ2 2025 (Jun 2025) | 17.91B | 2.36 | 17.6B | 18.23B | 9 |
| FQ1 2025 (Mar 2025) | 17.87B | 2.97 | 17.66B | 18.17B | 3 |
Quarterly Estimates Revisions
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Consensus EPS Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Consensus Revenue Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Earnings Surprise Summary
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Surprise (EPS) - Actual vs Consensus
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2024 (Dec 2024) | 5.63 | 5.63 | 100% | |
| FQ3 2024 (Sep 2024) | -11.5 | -11.5 | 100% | |
| FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | 5.93 | 5.93 | 100% | |
| FQ4 2023 (Dec 2023) | 6.05 | 6.05 | 100% | |
| FQ3 2023 (Sep 2023) | 3.97 | 3.97 | 100% | |
| FQ2 2023 (Jun 2023) | 4.34 | 4.34 | 100% | |
| FQ1 2023 (Mar 2023) | 4.92 | 4.92 | 100% |
Revenue Surprise - Actual vs Consensus
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2024 (Dec 2024) | $0B | $18.29B | $18285M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $17.49B | $17487M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $17.49B | $17492M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $17.34B | $17339M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $17.3B | $17303M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $16.21B | $16213M | 100% |
| FQ2 2023 (Jun 2023) | $0B | $15.86B | $15861M | 100% |
| FQ1 2023 (Mar 2023) | $0B | $15.59B | $15591M | 100% |
HCA Ratings Summary
HCA Quant Ranking
